All Outputs (2)

Making the case for pharmacogenomics in the management of mental health conditions (2023)
Journal Article
Berrou, I., Ramsunder, A., & Palmer, R. (2023). Making the case for pharmacogenomics in the management of mental health conditions. Pharmaceutical Journal, 310, 7969. https://doi.org/10.1211/PJ.2023.1.171747

Mental health conditions are the largest single cause of disability in the UK and among the top ten causes of disability worldwide. The prevalence of mental health conditions is increasing rapidly, especially since the COVID-19 pandemic. Overall, the... Read More about Making the case for pharmacogenomics in the management of mental health conditions.

Factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review (2022)
Journal Article
Alharbi, A. B., Berrou, I., Umaru, N., Al Hamid, A., & Shebl, N. A. (2023). Factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review. Research in Social and Administrative Pharmacy, 19(1), 28-56. https://doi.org/10.1016/j.sapharm.2022.07.003

Background: Regulatory medicines risk communications aim to prevent patient harm through the dissemination of safety information to healthcare professionals (HCPs), patients, and the public. Evidence suggests that in addition to implementing the requ... Read More about Factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review.